AFP and hepatocellular carcinoma: For many years, the most widely used blood biomarker was alpha-fetoprotein (AFP), however AFP has several limitations as lower sensitivity and weak specificity, making its use not satisfactory enough in the diagnosis of HCC (Chen et al., 2003).